Pentastatin, matrikine of the type IV collagen a5 drives pulmonary hypertension via endothelial dysfunction
A. Mutgan (Graz, Austria), K. Jandl (Graz, Austria), L. Marsh (Graz, Austria), J. Hoffmann (Graz, Austria), E. Gschwandtner (Vienna, Austria), W. Klepetko (Vienna, Austria), A. Heinemann (Graz, Austria), H. Olschewski (Graz, Austria), A. Olschewski (Graz, Austria), M. Wygrecka (Giessen, Germany), G. Kwapiszewska (Graz, Austria)
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Mutgan (Graz, Austria), K. Jandl (Graz, Austria), L. Marsh (Graz, Austria), J. Hoffmann (Graz, Austria), E. Gschwandtner (Vienna, Austria), W. Klepetko (Vienna, Austria), A. Heinemann (Graz, Austria), H. Olschewski (Graz, Austria), A. Olschewski (Graz, Austria), M. Wygrecka (Giessen, Germany), G. Kwapiszewska (Graz, Austria). Pentastatin, matrikine of the type IV collagen a5 drives pulmonary hypertension via endothelial dysfunction. 594
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: